Process for treating hemangioma

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3135

Patent

active

055524362

ABSTRACT:
A process and pharmaceutical composition for treatment of hemangioma in humans is disclosed. The pharmaceutical composition comprises a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a therapeutically effective amount of the composition is topically administered to a hemangioma of a human patient.

REFERENCES:
patent: 4271182 (1981-06-01), Sullivan
patent: 4362742 (1982-07-01), Sullivan
Habif, T. P., ed., Clinical Dermatology: A Color Guide to Diagnosis and Therapy, 2nd Ed., The C. V. Mosby Co. (St. Louis, Mo: 1989), pp. 582-585.
Brauenwald et al., eds., Harrison's Principals of Internal Medicine, 11th Ed., McGraw-Hill Book Co. (New York: 1990), pp. 1043, 1161, and 1958.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for treating hemangioma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for treating hemangioma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treating hemangioma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1950327

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.